Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUVAR for prevention of COVID-19
IRCT20200404046932N2Phase 3Completed
- Sponsor
- Hakiman-e Shargh Research
- Start
- Apr 2020
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind trial of Iota-carrageenan in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Hakiman-e Shargh Research. Primary endpoint: Rate of COVID-19 infection. Started Apr 2020; status: completed.
02
Drugs
Iota-carrageenan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200404046932N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200404046932N2.